The current medical treatment is supportive care. That is what's available, as it is for many respiratory viruses that don't have a specific vaccine or treatment. In terms of medical care, if someone has pneumonia you may need to support them with oxygen. If someone is really severe you may actually need ventilation. There's also hydration and making sure someone can recover from the illness.
There is an international collaborative effort to look at what the clinical course is and what kinds of treatments might be important. The world is scanning every single antiviral we already have available to see if it has activity against this particular virus, and that is a global collaborative approach. WHO is coordinating a lot of that as well. In Canada, we are pulling together our research organizations and our academic expertise in order to contribute to that global effort. That's on the treatment, on the antiviral side.
On the vaccine, there have been a number of vaccines that have been previously developed for coronaviruses, but not this specific one. The world, again, is pulling together everyone who actually has one of these vaccines and seeing what we can do to accelerate that development. What I can say is that even with the most rapid acceleration, I don't believe we are going to see a vaccine that is ready for probably a year. We have to plan for the fact that we're going to be managing this particular virus with no specific vaccine.